Difference between revisions of "Part:BBa K3610023:Design"

 
(→‎References)
Line 16: Line 16:
  
 
===References===
 
===References===
 +
McMahon, Lloyd P.; Choi, Kin M.; Lin, Tai-An; Abraham, Robert T.; Lawrence, John C. (2002): The Rapamycin-Binding Domain Governs Substrate Selectivity by the Mammalian Target of Rapamycin. In: Molecular and Cellular Biology 22 (21), S. 7428. DOI: 10.1128/MCB.22.21.7428-7438.2002.
 +
 +
Inobe T, Nukina N. Rapamycin-induced oligomer formation system of FRB-FKBP fusion proteins. J Biosci Bioeng. 2016;122(1):40-46. doi:10.1016/j.jbiosc.2015.12.004

Revision as of 22:33, 17 September 2020


FRB


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


Design Notes

none


Source

addgene.org

References

McMahon, Lloyd P.; Choi, Kin M.; Lin, Tai-An; Abraham, Robert T.; Lawrence, John C. (2002): The Rapamycin-Binding Domain Governs Substrate Selectivity by the Mammalian Target of Rapamycin. In: Molecular and Cellular Biology 22 (21), S. 7428. DOI: 10.1128/MCB.22.21.7428-7438.2002.

Inobe T, Nukina N. Rapamycin-induced oligomer formation system of FRB-FKBP fusion proteins. J Biosci Bioeng. 2016;122(1):40-46. doi:10.1016/j.jbiosc.2015.12.004